{"id":5783,"date":"2010-03-10T06:48:27","date_gmt":"2010-03-10T11:48:27","guid":{"rendered":"http:\/\/asweetlife.org\/?p=5783"},"modified":"2015-12-28T05:45:16","modified_gmt":"2015-12-28T10:45:16","slug":"diamyd-us-phase-iii-study-of-type-1-drug-well-on-the-way","status":"publish","type":"post","link":"https:\/\/asweetlife.org\/?p=5783","title":{"rendered":"Diamyd US Phase III study of Type 1 Drug Well on the Way"},"content":{"rendered":"<p style=\"text-align: justify;\"><a href=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif\" rel=\"mfp\"><img decoding=\"async\" class=\"alignleft size-full wp-image-5791 lazyload\" style=\"margin: 4px;\" title=\"Diamyd_logo\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif\" alt=\"\" width=\"166\" height=\"86\" \/><\/a>Diamyd Medical <a href=\"http:\/\/www.diamyd.com\/docs\/pressClip.aspx?section=investor&amp;ClipID=476726\" target=\"_blank\">announced<\/a> that 100 patients are now enrolled in the company&#8217;s US Phase III study called <a href=\"http:\/\/www.diaprevent.com\/\" target=\"_blank\">DiaPrevent<\/a> at 33 diabetes centers throughout the USA and more sites are to be added. The study will include 320 children and adolescents between 10 and 20 years of age, recently diagnosed with type 1 diabetes.<br \/> To date more than 430 children have received Diamyd\u00ae or placebo in the global Phase III program with no serious side effects related to the drug reported.<br \/> The global Phase III program aims to investigate whether Diamyd\u00ae can halt or slow the autoimmune destruction of beta cells in type 1 diabetes, preserving the body&#8217;s own ability to control blood sugar levels.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diamyd Medical announced that 100 patients are now enrolled in the company&#8217;s US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA and more sites are to be added. The study will include 320 children and adolescents between 10 and 20 years of age, recently diagnosed with type 1 diabetes&#8230;.<\/p>\n","protected":false},"author":131,"featured_media":5791,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1446],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.9 (Yoast SEO v22.9) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Diamyd US Phase III study of Type 1 Drug Well on the Way<\/title>\n<meta name=\"description\" content=\"Diamyd Medical announced that 100 patients are now enrolled in the company&#039;s US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/asweetlife.org\/?p=5783\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ASweetLife Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/asweetlife.org\/?p=5783\",\"url\":\"https:\/\/asweetlife.org\/?p=5783\",\"name\":\"Diamyd US Phase III study of Type 1 Drug Well on the Way\",\"isPartOf\":{\"@id\":\"https:\/\/asweetlife.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/asweetlife.org\/?p=5783#primaryimage\"},\"image\":{\"@id\":\"https:\/\/asweetlife.org\/?p=5783#primaryimage\"},\"thumbnailUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif\",\"datePublished\":\"2010-03-10T11:48:27+00:00\",\"dateModified\":\"2015-12-28T10:45:16+00:00\",\"author\":{\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\"},\"description\":\"Diamyd Medical announced that 100 patients are now enrolled in the company's US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA..\",\"breadcrumb\":{\"@id\":\"https:\/\/asweetlife.org\/?p=5783#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/asweetlife.org\/?p=5783\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/?p=5783#primaryimage\",\"url\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif\",\"contentUrl\":\"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif\",\"width\":166,\"height\":86,\"caption\":\"Diamyd_logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/asweetlife.org\/?p=5783#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/asweetlife.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Diamyd US Phase III study of Type 1 Drug Well on the Way\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/asweetlife.org\/#website\",\"url\":\"https:\/\/asweetlife.org\/\",\"name\":\"ASweetLife\",\"description\":\"The Diabetes Magazine\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/asweetlife.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585\",\"name\":\"ASweetLife Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/asweetlife.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g\",\"caption\":\"ASweetLife Team\"},\"url\":\"https:\/\/asweetlife.org\/?author=131\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Diamyd US Phase III study of Type 1 Drug Well on the Way","description":"Diamyd Medical announced that 100 patients are now enrolled in the company's US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/asweetlife.org\/?p=5783","twitter_misc":{"Written by":"ASweetLife Team","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/asweetlife.org\/?p=5783","url":"https:\/\/asweetlife.org\/?p=5783","name":"Diamyd US Phase III study of Type 1 Drug Well on the Way","isPartOf":{"@id":"https:\/\/asweetlife.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/asweetlife.org\/?p=5783#primaryimage"},"image":{"@id":"https:\/\/asweetlife.org\/?p=5783#primaryimage"},"thumbnailUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif","datePublished":"2010-03-10T11:48:27+00:00","dateModified":"2015-12-28T10:45:16+00:00","author":{"@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585"},"description":"Diamyd Medical announced that 100 patients are now enrolled in the company's US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA..","breadcrumb":{"@id":"https:\/\/asweetlife.org\/?p=5783#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/asweetlife.org\/?p=5783"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/?p=5783#primaryimage","url":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif","contentUrl":"https:\/\/asweetlife.org\/wp-content\/uploads\/2010\/03\/Diamyd_logo3.gif","width":166,"height":86,"caption":"Diamyd_logo"},{"@type":"BreadcrumbList","@id":"https:\/\/asweetlife.org\/?p=5783#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/asweetlife.org\/"},{"@type":"ListItem","position":2,"name":"Diamyd US Phase III study of Type 1 Drug Well on the Way"}]},{"@type":"WebSite","@id":"https:\/\/asweetlife.org\/#website","url":"https:\/\/asweetlife.org\/","name":"ASweetLife","description":"The Diabetes Magazine","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/asweetlife.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/5de2b093878b82b0ea97917f8fd72585","name":"ASweetLife Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/asweetlife.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ba76b5c6c27d32738b13f9a8a5cfcf02?s=96&d=mm&r=g","caption":"ASweetLife Team"},"url":"https:\/\/asweetlife.org\/?author=131"}]}},"_links":{"self":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/5783"}],"collection":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5783"}],"version-history":[{"count":0,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/posts\/5783\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=\/wp\/v2\/media\/5791"}],"wp:attachment":[{"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/asweetlife.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}